All In Biotech

Drug Trial Radar · NCT05729373

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

A Phase 2/3, Randomized, Double-blind, Parallel Group, Placebo-controlled, Flexible-dose, Multicenter Study to Evaluate the Efficacy and Safety of SEP-363856 in the Treatment of Adults With Generalized Anxiety Disorder

Last checked: Nov 20, 2026Latest source record: Oct 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 434 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

434

Actual

Start

Mar 8, 2023

Primary completion

Sep 26, 2025

Study completion Sep 26, 2025

Sponsor

Sponsor type
Industry
First posted
Feb 15, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A clinical study that will meaure how well SEP-363856 works and how safe it is in adults with Generalized Anixety Disorder. This study will be accepting both male and female subjects between the ages of 18 years and 65 years old. The study will be held in Approximately 50 global study centers and approximately 15 additional centers for a separate Japan population. Participation in the study can be up to approximately 12 weeks.

Conditions

  • Generalized Anxiety Disorder

Interventions

  • SEP-363856Drug

    once daily tablet

  • PlaceboDrug

    once daily tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Hamilton Anxiety Rating Scale (HAM-A) total score at EndpointTime frame: Week 8

Locations

83 sites in 8 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Huntsville, Alabama

  • IMA Clinical Research Phoenix

    Phoenix, Arizona

  • ProScience Research Group

    Culver City, California

  • Excell Research, Inc.

    Oceanside, California

  • Anderson Clinical Research

    Redlands, California

  • California Neuroscience Research, LLC

    Sherman, California

  • Schuster Medical Research Institute

    Sherman Oaks, California

  • Viking Pharmaceutical Trials Inc. dba Viking Clinical Research

    Temecula, California

  • CenExel Collaborative Neuroscience Research

    Torrance, California

  • Pacific Clinical Research Management Group

    Upland, California

  • CNS Healthcare

    Jacksonville, Florida

  • Combined Research Orlando

    Orlando, Florida

  • K2 Medical Research, LLC

    Tampa, Florida

  • CenExel iResearch Atlanta

    Atlanta, Georgia

  • Advanced Discovery Research LLC

    Atlanta, Georgia

  • NeuroTrials Research, Inc.

    Atlanta, Georgia

  • CenExel iResearch Savannah

    Savannah, Georgia

  • Uptown Research Institute, LLC

    Chicago, Illinois

  • American Medical Research, Inc.

    Warrenville, Illinois

  • Copley Clinical

    Boston, Massachusetts

  • Boston Clinical Trials

    Boston, Massachusetts

  • Adams Clinical

    Watertown, Massachusetts

  • Midwest Research Group

    Saint Charles, Missouri

  • Center for Emotional Fitness Site

    Cherry Hill, New Jersey

  • CenExel Hassman Research Institute

    Marlton, New Jersey

  • Social Psychiatry Research Institute

    Brooklyn, New York

  • Neurobehavioral Research, Inc.

    Cedarhurst, New York

  • Bioscience Research, LLC

    Mount Kisco, New York

  • Berman Clinical

    New York, New York

  • Manhattan Behavioral Medicine

    New York, New York

  • The Medical Research Network, L.L.C

    New York, New York

  • Neuro-Behavioral Clinical Research, Inc.

    North Canton, Ohio

  • Sooner Clinical Research

    Oklahoma City, Oklahoma

  • Paradigm Research Professionals, LLP

    Oklahoma City, Oklahoma

  • Lehigh Center for Clinical Research, LLC

    Allentown, Pennsylvania

  • Psychiatry and Psychotherapy Partners Austin

    Austin, Texas

  • FutureSearch Trials of Dallas, LP

    Dallas, Texas

  • Cedar Clinical Research, Inc.

    Draper, Utah

  • Medical Center Medconsult Pleven OOD

    Pleven, Bulgaria

  • MHC - Sofia, EOOD

    Sofia, Bulgaria

Showing 40 of 83 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.